EGF and non-small cell lung carcinoma: In prostate and non-small cell lung cancer cells, epidermal growth factor (EGF) can upregulate the expression of Nav1.7 and promote the migration of cancer cells (52, 53) or promote cell invasion through the ERK1 /2 pathway, respectively (54).